Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Diab Rep. 2011 Jun;11(3):160-6. doi: 10.1007/s11892-011-0187-x.

Bile acid metabolism and the pathogenesis of type 2 diabetes.

Author information

  • 1University Lille Nord de France; INSERM, U1011; UDSL; Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP245, 59019 Lille, France. janne.prawitt@inserm.fr

Abstract

Type 2 diabetes (T2D) is a growing health problem worldwide, but the currently available strategies for therapy and prevention are insufficient. Recent observations indicate that bile acid homeostasis is altered in T2D. Bile acids are metabolic regulators that act as signaling molecules through receptor-dependent and -independent pathways. The most prominent signaling molecules mediating bile acid signaling are the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor TGR5. Both are implicated in the regulation of lipid, glucose, and energy metabolism. Dysregulation of these pathways might contribute to the development of T2D and associated complications. Interestingly, data from studies with bile acids or bile acid sequestrants indicate that the manipulation of bile acid homeostasis might be an attractive approach for T2D therapy. In this review, we summarize the mechanisms of bile acid-mediated metabolic control that might be relevant in the pathogenesis of T2D.

PMID:
21431855
[PubMed - indexed for MEDLINE]
PMCID:
PMC3338411
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk